Abstract 1858P
Background
Identifying the patient's discomfort and unmet needs is crucial for providing effective care. However, accurately understanding the patient's discomfort can be challenging due to various limitations in the medical field, and in some cases, their discomfort may be underestimated. To better understand the difficulties faced by cancer patients, we implemented Social Listening to identify areas where improved treatment may be provided.
Methods
From October 1, 2021 to September 30, 2022, we gathered online data related to cancer and anti-cancer treatments. Using NetBase as our social listening platform, we filtered out irrelevant and commercial content from the collected data.
Results
A total of 169,575 social mentions related to cancer and anticancer treatment were collected. Among them, 12% (n=20,899) addressed the challenges experienced by patients following a cancer diagnosis. These challenges were further categorized based on the content of social media posts, with 52% focusing on physical difficulties, 42% on emotional challenges, and 6% on difficulties related to daily life. Emotional difficulties such as worry, denial, depression, fear, and anxiety were prevalent among cancer patients, with variations in priority depending on the time of diagnosis, treatment, and post-treatment stages. Of the 16,743 social media discussions related to cancer care, only 9% were related to managing emotional stress. A majority (84%) of discussions related to mental health management involved receiving psychiatric treatment, with the remaining 16% focusing on self-help groups, communication with others, meditation, hobbies, and religious practices.
Conclusions
Emotional burdens, along with physical difficulties, were frequently discussed on social media. However, there appeared to be a relative lack of focus on the management of emotional burdens. Considering the known association between emotional management and cancer treatment outcomes, it is imperative for physicians to prioritize their patients' emotional well-being and offer appropriate support.
Clinical trial identification
Editorial acknowledgement
Legal entity responsible for the study
The authors.
Funding
Korean Society of Medical Oncology.
Disclosure
All authors have declared no conflicts of interest.
Resources from the same session
1594P - End-of-life hospital cancer care in the COVID-19 era: A retrospective population-based study in the Netherlands
Presenter: Ellis Slotman
Session: Poster session 05
1595P - Incidence and characterization of end-of-life (EoL) systemic anticancer therapy (SACT) in melanoma patients (pts): A monocentric experience
Presenter: Silvia Buriolla
Session: Poster session 05
1596P - Exploring the economic impact of palliative care in oncology at the end of life
Presenter: Sarah Gomes
Session: Poster session 05
1597P - Improving in-hospital end-of-life care (EOLC) for oncology patients in a tertiary cancer centre
Presenter: Conor Moloney
Session: Poster session 05
1598P - Differences in referral patterns to the palliative care team among specialized physicians in patients with terminal cancer
Presenter: Hyun Jeong Shim
Session: Poster session 05
1599P - Clinical predictors of 30-day mortality in hospitalized patients with lung cancer: A retrospective single-center observational study
Presenter: Alessandro Leonetti
Session: Poster session 05
1600P - Sarcopenia, depression, and poor health perception among cancer patients registered in an oncology center in Pakistan
Presenter: Sobia Yaqub
Session: Poster session 05
1601P - Relationship between CT and ultrasonography-based sarcopenia and hematologic toxicity in patients with cancer receiving chemotherapy
Presenter: Gurkan Guner
Session: Poster session 05
1602P - Simulation training for compassionate extubation in the pediatric intensive care unit
Presenter: Nicole Fernandez
Session: Poster session 05
1603P - The ability of the LACE index to predict 30-day readmissions in oncology patients
Presenter: Burcu Ulas Kahya
Session: Poster session 05